This finding is in line with other studies in glioma [43]; breast cancer, lung cancer, and melanoma [30,44]; pancreatic cancer [45]; and gastric cancer [46], where an association between higher ANXA1 expression and lower survival has been described previously, all suggesting the involvement of ANXA1 in increased invasiveness and metastatic potential. Here, ANXA1 is linked to lung carcinoma.